Clinical Trials Logo

Filter by:
NCT ID: NCT03158363 Completed - Fasting Clinical Trials

A New Model of Acute Febrile Disease

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

The investigators want to establish a new model of acute febrile disease by mimicking the conditions seen in hospitalized patients in regards to inflammation, immobilisation and fasting. In this new model of disease, healthy young adults will be given lipopolysaccharide (LPS) to induce endotoxemia and inflammation/fever and then fast and bedrest for 36 hours. Glucose, fat and protein metabolism will be investigated using clamp technique and tracer methodology together with intracellular signalling pathway activation in muscle and fat biopsies. This new model of disease will later be used in another study to investigate different protein supplement´s effect on muscle waste during acute febrile disease.

NCT ID: NCT03157388 Completed - Alcoholic Hepatitis Clinical Trials

The Effect of Gut Sterilisation on Macrophage Activation in Patients With Alcoholic Hepatitis.

Start date: June 1, 2017
Phase: N/A
Study type: Interventional

Alcoholic hepatitis (AH) is a severe alcohol induced hepatic inflammation that leads to jaundice and liver failure. Gut derived bacterial translocation to the liver is currently thought to be one of the main inflammatory drivers of the disease. This project investigates the effects of gut sterilisation with broad spectrum antibiotics in patients with AH

NCT ID: NCT03157297 Completed - Clinical trials for Atrioventricular Conduction Block

Micra Atrial Tracking Using a Ventricular Accelerometer Study

MARVEL
Start date: July 10, 2017
Phase: Phase 1
Study type: Interventional

The purpose of this study is to characterize performance of the MARVEL algorithm downloaded into the MicraTM TPS to provide atrial synchronous ventricular pacing in subjects with AV block. A sub-study will be conducted within the Marvel study, the purpose of this study is to characterize the MARVEL algorithm in patients who were enrolled in the MARVEL study, and to collect and compare the accelerometer signals and AV synchrony at a second point in time.

NCT ID: NCT03157037 Completed - Clinical trials for Anti-Glomerular Basement Membrane Antibody Disease

Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease

GOOD-IDES-01
Start date: June 16, 2017
Phase: Phase 2
Study type: Interventional

This study will evaluate the safety and tolerability of IdeS in patients with severe anti-glomerular basement membrane (anti-GBM) disease receiving standard of care consisting of pulse-methylprednisolone, oral prednisolone and intravenous cyclophosphamide combined with plasma exchange (PLEX).

NCT ID: NCT03156920 Completed - Migraine Clinical Trials

Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers

Start date: May 23, 2017
Phase: N/A
Study type: Interventional

To develop a pragmatic migraine model the investigators will induce headache in healthy volunteers with a phosphodiesterase inhibitor (cilostazol). The participants will be pre-treated with sumatriptan. If the headache responds to sumatriptan, the model can be used to test new drug candidates.

NCT ID: NCT03155230 Completed - Chronic Pain Clinical Trials

Nationwide Results on Chronic Pain After Bilateral Transabdominal Preperitoneal Inguinal Hernia Repair (TAPP)

Start date: January 1, 2015
Phase:
Study type: Observational

Danish male patients who had undergone bilateral TAPP (July 2012 to June 2013) were recruited from the Danish Hernia Database and cross-checked with hospital files and the National Patient Registry. A standardized postal questionnaire was sent out two years after the index surgery to investigate Patients Related Outcome Measures (PROMs) such as chronic post-operative pain.

NCT ID: NCT03154944 Completed - Ileostomy - Stoma Clinical Trials

A Clinical Investigation Evaluating Three New 1-piece Ostomy Products

Start date: May 15, 2017
Phase: N/A
Study type: Interventional

This investigation evaluates three new ostomy appliances and their impact on the peristomal skin.

NCT ID: NCT03153137 Completed - Clinical trials for Congenital Heart Disease

Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects

RUBATO
Start date: August 14, 2017
Phase: Phase 3
Study type: Interventional

The primary objective is to assess the effect of macitentan 10 mg as compared to placebo on exercise capacity through cardiopulmonary exercise testing.

NCT ID: NCT03153111 Completed - Clinical trials for Heart Failure With Preserved Ejection Fraction

A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease

SERENADE
Start date: July 11, 2017
Phase: Phase 2
Study type: Interventional

This is a study to evaluate whether macitentan is an effective and safe treatment for patients with heart failure with preserved ejection fraction (HFpEF) and pulmonary vascular disease. The primary objective is to evaluate whether macitentan 10 mg reduces N-terminal pro-brain natriuretic peptide (NT-pro-BNP) as compared to placebo in these patients.

NCT ID: NCT03152734 Completed - Mortality Clinical Trials

Periinterventional Outcome Study in the Elderly

POSE
Start date: October 1, 2017
Phase:
Study type: Observational

The POSE study will predict critical stages and outcome in a large sample of all surgical and non-surgical interventional patients ≥80 years of age in Europe.